Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination

Vaccine

Volumn 30, Issue 31, 2012, Pages 4581-4584

  Li, Xi ^a   Miao, Hongyu ^a   Henn, Alicia ^a   Topham, David J ^a   Wu, Hulin ^a   Zand, Martin S ^a   Mosmann, Tim R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CD4 T cell; Influenza vaccine; Ki 67

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 2; KI 67 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-2; KI-67 ANTIGEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861985123     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.059     Document Type: Article

References (20)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA: The Journal of the American Medical Association 2004, 292:1333-1340. PubMed: 15367555.
2. Cox N.J., Subbarao K. Influenza. Lancet 1999, 354:1277-1282. PubMed: 10520648.
3. Swain S.L., Agrewala J.N., Brown D.M., Jelley-Gibbs D.M., Golech S., Huston G., et al. CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunological Reviews 2006, 211:8-22. PubMed: 16824113.
4. Thomas P.G., Keating R., Hulse-Post D.J., Doherty P.C. Cell-mediated protection in influenza infection. Emerging Infectious Diseases 2006, 12:48-54. PubMed: 16494717.
5. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. Journal of Immunology 2006, 176:6333-6339. PubMed: 16670345.
6. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. Journal of Virology 2006, 80:11756-11766. PubMed: 16971435.
7. Co M.D., Orphin L., Cruz J., Pazoles P., Rothman A.L., Ennis F.A., et al. Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine 2008, 26:1990-1998. PubMed: 18339461.
8. Roti M., Yang J., Berger D., Huston L., James E.A., Kwok W.W. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. Journal of Immunology 2008, 180:1758-1768. PubMed: 18209073.
9. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nature Reviews Immunology 2008, 8:247-258. PubMed: 18323851.
10. Verhoeven D., Teijaro J.R., Farber D.L. Heterogeneous memory T cells in antiviral immunity and immunopathology. Viral Immunology 2008, 21:99-113. PubMed: 18476772.
11. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. Journal of Immunology 1984, 133:1710-1715. 6206131.
12. Stubbe M., Vanderheyde N., Goldman M., Marchant A. Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. Journal of immunology 2006, 177:8185-8190. PubMed: 17114495.
13. van Leeuwen E.M., Sprent J., Surh C.D. Generation and maintenance of memory CD4(+) T cells. Current Opinion in Immunology 2009, 21:167-172. PubMed: 19282163.
14. Littleton R.J., Baker G.M., Soomro I.N., Adams R.L., Whimster W.F. Kinetic aspects of Ki-67 antigen expression in a normal cell line. Virchows Archiv. B: Cell Pathology Including Molecular Pathology 1991, 60:15-19. 1673272.
15. Cellerai C., Harari A., Vallelian F., Boyman O., Pantaleo G. Functional and phenotypic characterization of tetanus toxoid-specific human CD4+ T cells following re-immunization. European Journal of Immunology 2007, 37:1129-1138. PubMed: 17372991.
16. Divekar A.A., Zaiss D.M., Lee F.E., Liu D., Topham D.J., Sijts A.J., et al. Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-gamma-secreting cells. Journal of Immunology 2006, 176:1465-1473. PubMed: 16424174.
17. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006, 107:4781-4789. PubMed: 16467198.
18. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nature Medicine 2007, 13:843-850. PubMed: 17558415.
19. Demidenko E. Mixed models: theory and applications 2004, John Wiley and Sons, Inc., Hoboken, NJ.
20. Hedeker D., Gibbons R.D. Longitudinal data analysis 2006, John Wiley and Sons, Inc., Hoboken, NJ.